Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
about
A summary of the new GINA strategy: a roadmap to asthma controlYear in review 2014: Chronic obstructive pulmonary disease, asthma and airway biologyThe Danish National Database for Asthma: establishing clinical quality indicatorsGuidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsThree-month validation of a turbuhaler electronic monitoring device: implications for asthma clinical trial useBeta-agonist overuse and delay in obtaining medical review in high risk asthma: a secondary analysis of data from a randomised controlled trialReal-life use of budesonide/formoterol in clinical practice: a 12-month follow-up assessment in a multi-national study of asthma patients established on single-inhaler maintenance and reliever therapyThe use of β2-agonist therapy before hospital attendance for severe asthma exacerbations: a post-hoc analysisThe rapid effects of budesonide plus formoterol in patients with obstructive airway diseasesEfficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment.What are the pros and cons of electronically monitoring inhaler use in asthma? A multistakeholder perspective.The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.Respiratory allergies: a general overview of remedies, delivery systems, and the need to progressPharmacotherapy of critical asthma syndrome: current and emerging therapies.Orally inhaled fixed-dose combination products for the treatment of asthma and chronic obstructive pulmonary disease: not simple math.Combination budesonide/formoterol inhaler as maintenance and reliever therapy in Māori with asthma.Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis.A review of standard pharmacological therapy for adult asthma – Steps 1 to 5.Budesonide + formoterol fumarate dihydrate for the treatment of asthma.The influence of type of inhalation device on adherence of COPD patients to inhaled medication.Step 4: stick or twist? A review of asthma therapy.Effect of smoking status on the efficacy of the SMART regimen in high risk asthma.Combination ICS/fast-onset LABA inhaler as maintenance and reliever therapy: the future for uncontrolled adult asthma?Validation of a metered dose inhaler electronic monitoring device: implications for asthma clinical trial use.A Method to Calculate Adherence to Inhaled Therapy that Reflects the Changes in Clinical Features of Asthma.Experimentation with aerosol bonsetan, pirfenidone, treprostinil and sidenafil.Asthma attacks: how can we reduce the risks?Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma.Addressing ethnic disparity in asthma trials.A new combination therapy for asthma using dual-function dexamethasone-conjugated polyethylenimine and vitamin D binding protein siRNA.Real-Life Clinical Use of Symbicort® Maintenance and Reliever Therapy for Asthmatic Patients in Korea.Step 4: stick or twist? A review of asthma therapy.Effect of smoking status on the efficacy of the SMART regimen in high risk asthma - Reply
P2860
Q26799984-70C98A05-0696-419E-9B9D-9A6C852BF948Q27024394-9478B452-6E09-409E-B1CF-C43CAB617164Q28074257-1276F605-F3E8-4389-9EA3-89ED7CB9060DQ28392274-A6CB927F-4061-45B7-A0E9-F5C8AF0041D5Q30397096-4D932C80-4A36-41D4-9074-5670B25E5C0EQ33698626-FA0A5688-EBD7-4CA9-83B6-D76537866EA6Q35676597-17F63ABB-7409-4C10-9FE9-97194D51B1ECQ35939347-BE787ADF-EEA8-4FC4-9907-35E301F84EAFQ36110896-C68455DF-0291-485B-BEE5-2F4EBD22D440Q36352557-5FFDFF78-F859-433B-B01E-4DF9F666AC9BQ37464063-9D4B20BC-9304-4EC6-B91A-5882112AFBC1Q37576228-6BA04104-FBDB-470D-9A05-3407BCA03632Q37679681-3DBC50EB-9EDF-47E1-B154-A92F29F8F008Q38157770-B285A2BB-862F-468F-AB62-938A5F2F4FF1Q38193172-2C20E24C-72C2-4951-88A3-B1C5511BEC1FQ38217022-6ADD8D74-82C6-4864-BFE4-3EED1D0966D6Q38219526-F21CAB2E-28FE-42F1-8788-CF0089885F24Q38364832-8EFE54E4-AC44-474A-835B-C5A21AC78FA0Q38806274-0F9397C4-3038-4445-BF60-A4FC79D961D2Q38932081-2A58FA22-FE17-4C4D-92F5-F24492E7552EQ38960423-F828CF88-0547-4B79-8C4D-347D25A7A3D7Q39176351-A61A7F65-6A02-4B45-82CC-4B0761EC8C5FQ39218757-644D094F-3245-4DAE-ADDF-9402D3644D08Q39230410-FC9392AE-EA15-4A55-BB72-9822FA56F426Q39551071-C1923BE6-BEAA-4C23-B4AF-CF757BD16D07Q42084867-492E9EC1-0BC4-4A48-B2DA-89B17826F182Q42432096-CA937DBA-73F0-4699-966C-03B5937C64F8Q42572291-0998648C-6B06-4457-9953-03B58E39DA49Q43734431-C79C45C1-6DF4-4446-A39B-EC38E10B8436Q45871249-E55C05CC-FFD9-47F0-88A7-E4B99A2FEE26Q47117777-DC3B06AE-F239-403E-BA34-FE75507D33C2Q54887789-2EEF3D4A-7B09-44F7-8314-417F269C0B93Q57786053-8394315C-4525-42C4-A5C4-C2D5DE84F6EE
P2860
Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Efficacy and safety of mainten ...... a randomised controlled trial.
@en
type
label
Efficacy and safety of mainten ...... a randomised controlled trial.
@en
prefLabel
Efficacy and safety of mainten ...... a randomised controlled trial.
@en
P2093
P50
P1476
Efficacy and safety of mainten ...... a randomised controlled trial.
@en
P2093
Janine Pilcher
Kyle Perrin
Mark Weatherall
Mitesh Patel
Peter Black
SMART Study Group
Shaun Holt
P356
10.1016/S2213-2600(13)70007-9
P577
2013-03-04T00:00:00Z